Overview
| Gender | Male |
|---|---|
| israel.lowy@mssm.edu | |
| Education and Training | MD/PhD, Columbia University |
| AB, Princeton University | |
| Fellowship, Presbyterian Hospital, Columbia University | |
| Residency, Presbyterian Hospital, Columbia University |

| Gender | Male |
|---|---|
| israel.lowy@mssm.edu | |
| Education and Training | MD/PhD, Columbia University |
| AB, Princeton University | |
| Fellowship, Presbyterian Hospital, Columbia University | |
| Residency, Presbyterian Hospital, Columbia University |
| Education and Training | MD/PhD, Columbia University |
|---|---|
| AB, Princeton University | |
| Fellowship, Presbyterian Hospital, Columbia University | |
| Residency, Presbyterian Hospital, Columbia University |
molecular biology and application of human T-cell immortalization with Herpesvirus saimiri
Jacobson J, Lowy I, Fletcher CV, O'Neill TJ, Tran DN, Ketas TJ, Trkola A, Klotman M, Maddon PJ, Olson WC, Israel RJ. Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adults. J Infect Dis 2000 Jul; 182(1): 326-9.
The Mount Sinai Medical Center is home to an extensive array of top-notch research centers and laboratories, where scientists and researchers work to translate the rapid advances in basic science into the innovative patient care for which we are known.
Participating in Mount Sinai’s clinical trials allows you to take advantage of innovative treatments as we work together to advance the future of medicine.